The report, presented by researchers at the Centers for Disease Control and Prevention (CDC), finds:
- In 2010, the total national medical costs attributable to COPD were estimated at $32.1 billion dollars annually.
- Absenteeism costs were $3.9 billion for a total burden of $36 billion in COPD-attributable costs.
- An estimated 16.4 million days of work were lost due to COPD each year.
- Of the medical cost, 18% was paid for by private insurance, 51% by Medicare, and 25% by Medicaid.
- The study also projects a rise in medical costs from $32.1 billion in 2010 to $49 billion by 2020.
Results: In 2010, total national medical costs attributable to COPD and its sequelae were estimated at $32.1 billion and total absenteeism costs were $3.9 billion for a total burden of COPD-attributable costs of $36 billion. An estimated 16.4 million days of work were lost because of COPD. Of the medical costs, 18% was paid for by private insurance, 51% by Medicare, and 25% by Medicaid. National medical costs are projected to increase from $32.1 billion in 2010 to $49.0 billion in 2020. Total state-specific costs in 2010 ranged from $49.1 million in Wyoming to $2.8 billion in California: medical costs ranged from $42.5 million in Alaska to $2.5 billion in Florida and absenteeism costs ranged from $8.4 million in Wyoming to $434.0 million in California.
Conclusion: Costs attributable to COPD and its sequelae are substantial and are projected to increase through 2020. Evidence-based interventions that prevent tobacco use and reduce clinical complications of COPD may result in potential decreased COPD-attributable costs.